Method for deacetylation of biopolymers

US11254792B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11254792-B2
Application numberUS-201616066746-A
CountryUS
Kind codeB2
Filing dateDec 28, 2016
Priority dateDec 29, 2015
Publication dateFeb 22, 2022
Grant dateFeb 22, 2022

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A method for at least partial deacetylation of a biopolymer comprising acetyl groups, including: a1) providing a biopolymer including acetyl groups; a2) reacting the biopolymer including acetyl groups with hydroxylamine (NH2OH) or a salt thereof at a temperature of 100° C. or less for 2-200 hours to form an at least partially deacetylated biopolymer; and a3) recovering the at least partially deacetylated biopolymer.

First claim

Opening claim text (preview).

The invention claimed is: 1. A method of preparing a hydrogel product comprising crosslinked glycosaminoglycan molecules, the method comprising: (a) obtaining a solution comprising an at least partially deacetylated glycosaminoglycan with a degree of acetylation between 50% and 99% and a second glycosaminoglycan, wherein the second glycosaminoglycan is different from the at least partially deacetylated glycosaminoglycan; (b) activating carboxyl groups on the at least partially deacetylated glycosaminoglycan and/or the second glycosaminoglycan with a coupling agent, to form activated glycosaminoglycans; (c) crosslinking the activated glycosaminoglycans via two different crosslinkers solely with amide bonds to provide crosslinked glycosaminoglycans; and (d) acylating residual amine groups of the crosslinked glycosaminoglycans obtained in (c) to form acylated crosslinked glycosaminoglycans; and (e) subjecting the crosslinked glycosaminoglycans provided in (c) or (d) to alkaline treatment to hydrolyze ester crosslinks formed as byproducts during the amide crosslinking in (c), wherein the first and second glycosaminoglycans are not the two different crosslinkers, and wherein the two different crosslinkers are carbohydrate-based crosslinkers. 2. The method according to claim 1 , wherein the second glycosaminoglycan is at least partially deacetylated. 3. The method according to claim 1 , wherein the second glycosaminoglycan is not deacetylated. 4. The method according to claim 1 , wherein the glycosaminoglycans are selected from hyaluronic acid, chondroitin, chondroitin sulphate, heparin sulphate, heparosan, heparin, dermatan sulphate, and keratin sulphate. 5. The method according to claim 1 , wherein the at least partially deacetylated glycosaminoglycan and/or the second glycosaminoglycan is hyaluronic acid. 6. The method according to claim 1 , wherein the at least partially deacetylated glycosaminoglycan and the second glycosaminoglycan are hyaluronic acids. 7. The method according to claim 1 , wherein (b) and (c) occur simultaneously. 8. The method according to claim 1 , wherein (b) occurs prior to (c). 9. The method according to claim 1 , wherein the hydrogel product comprises a portion of glycosaminoglycans which are not crosslinked. 10. The method according to claim 9 , wherein the crosslinked glycosaminoglycan molecules comprise at least 80% by weight of the hydrogel product. 11. The method according to claim 1 , wherein the at least partially deacetylated glycosaminoglycan has a degree of acetylation between 93% and 99%. 12. The method according to claim 1 , wherein the second glycosaminoglycan obtained in a) is not altered or modified by addition or removal of functional groups. 13. The method according to claim 1 , wherein at least one of the two different crosslinkers is diaminotrehalose.

Assignees

Inventors

Classifications

  • Chondroitin-4-sulfate, i.e. chondroitin sulfate A; Dermatan sulfate, i.e. chondroitin sulfate B or beta-heparin; Chondroitin-6-sulfate, i.e. chondroitin sulfate C; Derivatives thereof · CPC title

  • General cosmetic use · CPC title

  • Preparations for care of the skin · CPC title

  • Gels · CPC title

  • Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11254792B2 cover?
A method for at least partial deacetylation of a biopolymer comprising acetyl groups, including: a1) providing a biopolymer including acetyl groups; a2) reacting the biopolymer including acetyl groups with hydroxylamine (NH2OH) or a salt thereof at a temperature of 100° C. or less for 2-200 hours to form an at least partially deacetylated biopolymer; and a3) recovering the at least partially de…
Who is the assignee on this patent?
Galderma Holding SA
What technology area does this patent fall under?
Primary CPC classification C08B37/0069. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Feb 22 2022 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).